Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Mavissakalian, J. Perel (1995)
Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.The American journal of psychiatry, 152 5
D. Sheehan, Y. Lecrubier, K. Sheehan, J. Janavs, E. Weiller, A. Keskiner, J. Schinka, E. Knapp, M. Sheehan, G. Dunbar (1997)
The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliabilityEuropean Psychiatry, 12
L. Labbate, Jamie Grimes, G. Arana (1998)
Serotonin reuptake antidepressant effects on sexual function in patients with anxiety disordersBiological Psychiatry, 43
Y Lecrubier, A Bakker, G Dunbar, R Judge (1997)
Collaborative Paroxetine Panic Study Investigators: A comparison of paroxetine, clomipramine, and placebo in the treatment of panic disorderActa Psychiatry Scand, 95
M. Mavissakalian, J. Perel, M. Talbott-Green, C. Sloan (1998)
Gauging the Effectiveness of Extended Imipramine Treatment for Panic Disorder with AgoraphobiaBiological Psychiatry, 43
Y. Lecrubier, A. Bakker, G. Dunbar, R. Judge (1997)
A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorderActa Psychiatrica Scandinavica, 95
P. Londborg, R. Wolkow, Ward Smith, E. Duboff, Donald England, J. Ferguson, M. Rosenthal, C. Weise (1998)
Sertraline in the treatment of panic disorderBritish Journal of Psychiatry, 173
M. Hamilton (1960)
A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 23
L. Piazza, J. Markowitz, J. Kocsis, A. Leon, L. Portera, N. Miller, D. Adler (1997)
Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study.The American journal of psychiatry, 154 12
DV Sheehan, Y Lecrubier, K Harnett-Sheehan, J Janavs, E Weiller, A Keskiner, J Schinka, E Knapp, MF Sheehan, GC Dunbar (1997)
Reliability and validity of the MINI international neuropsychiatric interview (M.I.N.I): according to the SCID-PEur Psychiatry, 12
RA Peterson, S Reiss (1992)
Anxiety Sensitivity Index Revised Test Manual
D. Bakish, C. Hooper, M. Filteau, Y. Charbonneau, G. Fraser, D. West, C. Thibaudeau, D. Raine (1996)
A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.Psychopharmacology bulletin, 32 1
SA Montgomery, JC Nelson (2000)
Novel Antidepressant Strategies to Optimize Outcome (Academic Highlights)J Clin Psychiatry, 61
A. Beck, C. Ward, M. Mendelson, J. Mock, J. Erbaugh (1961)
An inventory for measuring depression.Archives of general psychiatry, 4
A. Wade, U. Lepola, H. Koponen, V. Pedersen, T. Pedersen (1997)
The effect of Citalopram in panic disorderBritish Journal of Psychiatry, 170
M. Versiani, G. Cassano, G. Perugi, A. Benedetti, L. Mastalli, A. Nardi, M. Savino (2002)
Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.The Journal of clinical psychiatry, 63 1
M. Mavissakalian, James Perel (1999)
Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.Archives of general psychiatry, 56 9
MR Ware, NP Emmanuel, MR Johnson, O Brawman-Mintzer, R Knapp, M Crawford-Harrison, RB Lydiard (1996)
Self-reported sexual dysfunctions in anxiety disorder patientsPsychopharmcol Bull, 32
Isaac Marks, A. Mathews (1979)
Brief standard self-rating for phobic patients.Behaviour research and therapy, 17 3
D. Newport, A. Hostetter, Angela Arnold, Z. Stowe (2002)
The treatment of postpartum depression: minimizing infant exposures.The Journal of clinical psychiatry, 63 Suppl 7
M. Mavissakalian, J. Perel, C. Groot (1993)
Imipramine treatment of panic disorder with agoraphobia: the second time around.Journal of psychiatric research, 27 1
MR Mavissakalian, JM Perel (1995)
Imipramine in panic disorder with agoraphobia: dose ranging and plasma level-response relationshipsAm J Psychiatry, 152
M. Mavissakalian, J. Perel (2000)
The side effects burden of extended imipramine treatment of panic disorder.Journal of clinical psychopharmacology, 20 5
M. Mavissakalian, J. Perel, Shenyang Guo (2002)
Specific Side Effects of Long-Term Imipramine Management of Panic DisorderJournal of Clinical Psychopharmacology, 22
Despite the acknowledged favorable side effects profile of selective serotonin reuptake inhibitors (SSRIs), comparative studies have not found significant differences in efficacy between tricyclics (TCAs) such as imipramine and clomipramine, and SSRIs in the treatment of panic disorder. The present study focuses on treatment completers to inform patients who adhere to a recommended course of treatment on the possible differential patterns of improvement and of change in side effects between sertraline and imipramine. From an intent to treat consecutive sample of patients participating in the 24-week open phase protocolized treatment of a long-term controlled maintenance/discontinuation study, 20 imipramine completers and 16 sertraline completers with moderate to severe baseline symptomatology were compared using primarily repeated measures analysis of variance on measures of symptom severity, on 15 side effects systematically elicited using an inventory and on heart rate and weight. The results revealed greater early improvement with imipramine compared to sertraline but no enduring differences beyond week 8 of treatments. Side effects, in particular dry mouth, constipation, tremors, sweating, and cardiovascular complaints increased more in severity and were more frequent and persistent during imipramine than sertraline but, except for the 10 beats/min increase in heart rate, side effects were clinically insignificant at the end of both treatments. Change in sexual complaints and weight did not differ between the treatments. The more favorable side effect profile of SSRIs versus TCAs was demonstrated even in the best case scenario of treatment completers. The more rapid improvement with imipramine needs replication but, tentatively, it may be attributed to the greater motivational effects toward action observed with noradrenergic or dual action antidepressants compared to SSRIs.
Annals of Clinical Psychiatry – Springer Journals
Published: Oct 11, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.